On May 24, 2012, Christopher D. Alafi informed the Board of Directors of Stereotaxis Inc. that he does not intend to stand for re-election as a director at the Company's 2012 Annual Meeting of Stockholders, which is expected to be held in August 2012. On May 30, 2012, the company announced that William C. Mills, III, has been appointed Chairman of the Board of Directors of the Company, effective immediately. Mr. Mills succeeds Fred A. Middleton who will remain on the board of directors of the Company.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation, fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Companyâs primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.
STEREOTAXIS, INC. 
